Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

17.40
-0.0500-0.29%
Post-market: 17.400.00000.00%16:20 EDT
Volume:1.79M
Turnover:31.34M
Market Cap:2.23B
PE:-43.26
High:18.18
Open:17.40
Low:17.26
Close:17.45
52wk High:19.76
52wk Low:7.07
Shares:128.00M
Float Shares:117.00M
Volume Ratio:0.79
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4023
EPS(LYR):-0.8433
ROE:-6.33%
ROA:-1.89%
PB:2.83
PE(LYR):-20.63

Loading ...

NeoGenomics Resolves DOJ Investigation, Refocuses on Cancer Care

TIPRANKS
·
Jul 21

Neogenomics Settlement Comes in Under Accrued Reserves

Dow Jones
·
Jul 21

Neogenomics Resolves DOJ Investigation

Dow Jones
·
Jul 21

NeoGenomics announces settlement of voluntary disclosure to OIG-HHS

TIPRANKS
·
Jul 21

Neogenomics Agrees to Pay USD 9.81 Million to Settle DOJ Probe Tied to Lab Collaboration Program

Reuters
·
Jul 21

Neogenomics - to Pay $9.81 Mln Plus 4.25% Interest from Jan 16, 2026 to Resolve Matter

THOMSON REUTERS
·
Jul 21

Neogenomics - Finalizes Civil Settlement with DOJ and Oig Resolving Investigation

THOMSON REUTERS
·
Jul 21

Neogenomics Announces Settlement of Voluntary Disclosure to Oig-hhs

THOMSON REUTERS
·
Jul 21

Xi'an Jiaotong University Receives Another Anonymous Donation, This Time Totaling 30 Million Yuan

Deep News
·
Jul 19

International Student Deceives Elderly Parents into Borrowing Millions, Sentenced to 11 Years for Fraud

Deep News
·
Jul 19

Neo Performance Materials Inc (NEO) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
Jul 16

Sidoti Reaffirms Their Hold Rating on Neo Performance Materials Inc (NEO)

TIPRANKS
·
Jul 14

ATB Cormark Capital Markets Reaffirms Their Buy Rating on Neo Performance Materials Inc (NEO)

TIPRANKS
·
Jul 14

Does NeoGenomics (NEO) New PTEN CDx Move Reveal a Deeper Precision Oncology Strategy Shift?

Simply Wall St.
·
Jul 14

NeoGenomics Launches First FDA-Approved Prostate Cancer Companion Diagnostic

Deep News
·
Jul 09

NeoGenomics launches FDA-approved PTEN IHC prostate Cancer ompanion diagnostic

TIPRANKS
·
Jul 09

Neogenomics Launches Fda-approved Pten Ihc Companion Diagnostic for Prostate Cancer

THOMSON REUTERS
·
Jul 09

Press Release: Neogenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

Dow Jones
·
Jul 07

Neogenomics on Track for Longest Winning Streak Since February 2019

Dow Jones
·
Jul 06

ATB Cormark Capital Markets Keeps Their Buy Rating on Neo Performance Materials Inc (NEO)

TIPRANKS
·
Jun 30